The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Naltrexone: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Opioid Dependence
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the specificity of naloxone as an opiate antagonist
Sawynok, J., Pinsky, C., & LaBella, F. S. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90403-x · Cited by 614
Naltrexone, an Antagonist for the Treatment of Heroin Dependence: Effects in Man
Martin, W. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360022003 · Cited by 392
THE HUMAN PHARMACOLOGY AND ABUSE POTENTIAL OF N-ALLYLNOROXYMORPHONE (NALOXONE)
Jasinski, D. R., Martin, W. R., & Haertzen, C. A. (1967) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27721-7 · Cited by 283
Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing
Verebey, K., Volavka, J., Mule, S. J., & Resnick, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976203315 · Cited by 270
Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist
RESNICK, R. B., VOLAVKA, J., FREEDMAN, A. M., & THOMAS, M. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.6.646 · Cited by 197
Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet
Apfelbaum, M., & Mandenoff, A. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90344-0 · Cited by 186
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
Meyer, M. C., Straughn, A. B., Lo, M. W., Schary, W. L., & Whitney, C. C. (1984) · PubMed · Cited by 168
Effects of long-term therapy with naltrexone on body weight in obesity
Atkinson, R. L., Berke, L. K., Drake, C. R., Bibbs, M. L., Williams, F. L., & Kaiser, D. L. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.197 · Cited by 163
Effects of naltrexone on mood and neuroendocrine function in normal adult males
Mendelson, J. H. (1978) · Psychoneuroendocrinology · doi:10.1016/0306-4530(78)90013-6 · Cited by 143
Aversive effects of naltrexone in subjects not dependent on opiates
Hollister, L. E., Johnson, K., Boukhabza, D., & Gillespie, H. K. (1981) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(81)90084-3 · Cited by 131
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
Barski, O. A., Tipparaju, S. M., & Bhatnagar, A. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530802431439 · Cited by 542
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336
Crain, S. M., & Shen, K.-F. (2000) · Pain · doi:10.1016/s0304-3959(99)00223-7 · Cited by 306
Metadata
- Authors
- Gonzalez, J. P., & Brogden, R. N.
- Venue
- Drugs
- Published
- 1988-03
- Volume
- 35
- Issue
- 3
- Pages
- 192-213
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W2030028793
- Cited by
- 314
- References
- 74
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naltrexone: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Opioid Dependence. https://app.cochat.ai/papers/10.2165/00003495-198835030-00002
- The paper
- Gonzalez, J. P., & Brogden, R. N. (1988). Naltrexone: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Opioid Dependence. Drugs. https://doi.org/10.2165/00003495-198835030-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.